Analysis reveals rising morbidity and mortality rates in patients with COVID-19 and chronic conditions, suggesting pharmacotoxicologic factors are influential.
Before the COVID-19 pandemic, various statistical data and research group studies revealed a significant decrease in morbidity and mortality rates (MMRs) among different patient populations. However, unexpected increases in excessive MMRs among long-term COVID-19 patients, cancer patients, and those with cardiovascular diseases, along with a temporary decrease in the 5-/ 10-year survival rates for different subjects, have become a reality in the post-COVID-19 era.
No takes yet. Share an insight, caveat, or question.
Bahram Alamdary Badlou (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: